Titan Medical Inc (TITXF) 1.0600 $TITXF Medical Robotics

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Titan Medical Inc (TITXF) 1.0600 $TITXF

Medical Robotics Market Analysis 2015-2020 - The Market is Estimated to Grow at a CAGR 12% from 2014 to 2020
M2 - Wed Aug 12, 2:58AM CDT
Research and Markets (http://www.researchandmarkets.com/research/976kgq/medical_robotics) has announced the addition of the "Medical Robotics Market Analysis (2015 -2020): By Type (Surgical, Rehabilitation, Percutaneous, Non-invasive); By Specialization (Neurology, Laparoscopy, Orthopaedics, Cardiovascular)" report to their offering. Medical Robotics Market Analysis (2015 -2020): By Type (Surgical, Rehabilitation, Percutaneous, Non-invasive); By Specialization (Neurology, Laparoscopy, Orthopaedics, Cardiovascular) The Global Market for Medical Robotics is a diversified medical robotic systems market. Medical Robotics provides accuracy, reduction in errors and greater safety in healthcare. Application of Medical Robotics in healthcare has observed a significant rise over the years. The Global Medical Robotics Market is estimated to be growing at a CAGR 12% from 2014 to 2020. Medical reimbursements to hospitals using surgical robots and prostatectomies robotics have observed an upsurge in countries like the US. A detailed qualitative analysis of the factors responsible for driving and restraining growth of the Global Medical Robotics Market and future opportunities are provided in the report. This report on the Global Medical Robotics Market identifies many such insights and M&A opportunities, besides providing a detailed analysis of the Medical Robotics Market. Key Topics Covered: 1. Medical Robotics Market - Market Overview 2. Executive Summary 3. Medical Robotics Market - Market Landscape 4. Medical Robotics Market - Market Forces 5. Medical Robotics Market- Strategic Analysis 6. Medical Robotics Market- By Type 7. Medical Robotics Market- By End User 8. Medical Robotics Market- By Application 9. Medical Robotics Market - Geographic Analysis 10. Market Entropy 11. Company Profiles (Overview, Financials, SWOT Analysis - Top 5 Companies, Developments, Product Portfolio) 12. Appendix Companies Mentioned - Hansel Medican, Inc. - Intuitive Surgical Inc. - Mazor Robotics - Accuray Inc. - Titan Medical Inc. - Curexo Technology Corporation - Renishaw - MedTech Co. - KUKA Laboratories - iRobot - Ekso Bionics - Telelap ALF-X - Varian Medical Systems - Motorika - Stereotaxis - Myomo - ZOLL Medical Corp. - Stanmore Implants - InTouch Health Technologies, Inc. - Medrobotics Corporation - McKesson Corporation - Kinova Robotics - Corindus Vascular Robotics - OR Productivity Plc. For more information visit http://www.researchandmarkets.com/research/97...l_robotics
ISRG: 515.30 (+3.76), MCK: 197.64 (+2.53), VAR: 79.25 (-0.33), CVRS: 3.94 (+0.12), MZOR: 11.44 (-0.41), ARAY: 6.47 (+0.03)

Titan Medical Inc. Announces Results for the Three and Six Months Ended June 30, 2015
Marketwired - Tue Aug 11, 4:24PM CDT
Titan Medical Inc. ("Titan" or the "Company" (TSX: TMD) (OTCQX: TITXF) today announced financial results for the three and six months ended June 30, 2015. All financial results are reported in U.S. dollars, unless otherwise stated.
TMD.TO: 1.41 (unch)

Titan Medical Files Preliminary Short Form Base Shelf Prospectus
Marketwired - Fri Jul 24, 1:11PM CDT
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
TMD.TO: 1.41 (unch)

Titan Medical Inc. Announces Option Agreement With Platform Imaging, LLC
Marketwired - Tue Jun 16, 6:15AM CDT
Titan Medical Inc. ("Titan" or the "Company" (TSX: TMD) (OTCQX: TITXF) today announced that it has signed an Option Agreement with Platform Imaging, LLC to acquire the exclusive rights to integrate camera control software into the SPORT(TM) Surgical System. This sophisticated tool-tracking software will enable automation of the pan and tilt functions of the camera module to provide surgeons with a view of the surgical field without the need to manually position and reposition the camera.
TMD.TO: 1.41 (unch)

Titan Medical Inc. (TSX: TMD) (OTCQX: TITXF) Announces the Voting Results From Its Annual and Special Meeting of Shareholders Held on June 9, 2015
Marketwired - Wed Jun 10, 3:15PM CDT
Titan Medical Inc. ("Titan" or the "Company" (TSX: TMD) (OTCQX: TITXF) announces the voting results from its Annual and Special Meeting of shareholders held on June 9, 2015.
TMD.TO: 1.41 (unch)

Titan Medical Inc. Grants Stock Options
Marketwired - Tue Jun 09, 2:54PM CDT
Titan Medical Inc. (the "Company" (TSX: TMD)(OTCQX: TITXF) announced today that the Company has granted, effective June 9, 2015, a total of 684,752 incentive stock options to Directors, Officers, Employees and Consultants pursuant to its incentive stock option plan. These stock options are exercisable until June 9, 2020, at a price of $1.72. The stock options granted to Independent Directors and Consultants vest immediately. Stock Options granted to Officers and Employees vest over three years.
TMD.TO: 1.41 (unch)

Global Surgical Robots Market Shares, Strategies, and Forecasts, Worldwide, 2015 to 2021
M2 - Thu May 14, 8:42AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lhrlvh/surgical_robots) has announced the addition of Wintergreen Research, Inc's new report "Surgical Robots Market Shares, Strategies, and Forecasts, Worldwide, 2015 to 2021" to their offering. Surgical robot device markets at $3.2 billion in 2014 are anticipated to reach $20 billion by 2021 as next generation devices, systems, and instruments are introduced to manage surgery through small ports in the body instead of large open wounds. The complete report provides a comprehensive analysis including procedure numbers, units sold, market value, forecasts, as well as a detailed competitive market shares and analysis of major players' success, challenges, and strategies in each segment and subsegment. The reports cover markets for: medical specialties and sub-specialties. The new study Surgical Robots: Market Shares, Strategy, and Forecasts, Worldwide, 2015 to 2021 has 553 pages, 216 tables and figures. Worldwide surgical robot markets are poised to achieve significant growth as next generation systems provide a way to improve traditional open surgery and decrease the number of ports needed for minimally invasive surgery. Intuitive Surgical has market leadership position, advanced technology, an impressive installed base and a well trained group of surgeons able to manage the robots. Patients fare better when the surgery is done by surgical robots. The documentation of improvements in care delivery, the ability to ensure better outcomes from surgery promise that surgical robotics is a strong growth market. Intuitive Surgical will be difficult to dislodge, its dominant position is based on technological excellence that keeps being improved and competitors have a difficult time catching up, much less improving on the Intuitive Surgical technology. Other leading competitors will emerge and the group of several surgical robotic companies will collectively have enough marketing dollars and enough marketing clout to drive replacement of all open surgery. Robotic surgery is positioned to become the standard of care. Intuitive Surgical has achieved market saturation in colorectal surgery in the US, it will work on increasing its presence in other surgical market sectors. The leading robotic surgical companies are poised to grow through acquisition, purchasing smaller companies that have developed as specialized product and gained FDA approval. As detailed in the market research study there are a lot of those in every medical specialty and more to come. Key Topics Covered: 1. Surgical Robots Market Description and Market Dynamics 2. Surgical Robot Market Shares and Forecasts 3. Surgical Robots Product Description 4. Medical Robot Technology 5. Surgical Robots Company Description Companies Mentioned - AVRA Surgical - Accel Spine - Accuray - Aesynt / Health Robotics - Alliance Spine - Amedica - Elekta AB - Freehand 2010 - Globus Medical - Hansen Medical - Healthcare Robotics Lab - Intuitive Surgical - Johnson and Johnson / DePuy Synthes - Medrobotics - Medtronic - NLT Spine - NuVasive - Otto Bock HealthCare - Precision Spine - RTI Biologics / Pioneer Surgical Technology - Restoration Robotics - SI-BONE 503 - Spinal Elements - SpineGuard - Spineart - Spineology - Stryker - Think Surgical - Titan Medical - TranS1 - UC Berkeley - Varian Medical Systems. - Vecna Robotics - Victrex plc / Invibio - Vycor For more information visit http://www.researchandmarkets.com/research/lh...cal_robots Source: Wintergreen Research, Inc
ISRG: 515.30 (+3.76), JNJ: 92.93 (+0.21), RTIX: 6.18 (+0.03), VAR: 79.25 (-0.33), MDT: 69.90 (-0.11), HNSN: 0.53 (-0.03), GMED: 23.46 (+0.25)

Titan Medical Inc. Named to 2015 OTCQX Best 50
Marketwired - Wed May 13, 3:30PM CDT
Titan Medical Inc. (TSX: TMD) (OTCQX: TITXF) is pleased to announce it has been named to the 2015 OTCQX® Best 50, a ranking of 50 top performing companies traded on the OTCQX Best Marketplace last year.
TMD.TO: 1.41 (unch)

Titan Medical Inc. Announces Results for the Three Months Ended March 31, 2015
Marketwired - Tue May 12, 3:30PM CDT
Titan Medical Inc. ("Titan" or the "Company" (TSX: TMD) (OTCQX: TITXF) today announced financial results for the three months ended March 31, 2015. All financial results are reported in U.S. dollars, unless otherwise stated.
TMD.TO: 1.41 (unch)

Titan Medical Inc. Adopts Shareholders Rights Plan
Marketwired - Fri May 08, 3:30PM CDT
Titan Medical Inc. ("Titan" or the "Company" (TSX: TMD) (OTCQX: TITXF) Titan Medical Inc. announces that it has adopted a shareholder rights plan (the "Plan" effective May 8, 2015. The Company will be seeking shareholder approval of the Plan at its upcoming annual and special meeting of shareholders to be held on June 9, 2015.
TMD.TO: 1.41 (unch)

Titan Medical Inc. and Anne Arundel Medical Center's Innovation Center Announce Agreement for Development of a Comprehensive Training Curriculum for the Use of the SPORT(TM) Surgical System
Marketwired - Tue May 05, 6:31AM CDT
Titan Medical Inc. ("Titan" or the "Company" (TSX: TMD) (OTCQX: TITXF) today announced that it has signed an agreement with the James and Sylvia Earl Simulation to Advance Innovation and Learning (SAIL) center at Anne Arundel Medical Center (AAMC) in Annapolis, MD, for the development of a comprehensive curriculum for training and performance assessment. The curriculum would be developed for training the surgeons and surgical teams who would use Titan's SPORT(TM) Surgical System.
TMD.TO: 1.41 (unch)

Titan Medical Inc. Signs Agreement With Worldwide Supplier of Single Patient Use Robotic Tools
Marketwire Canada - Thu Apr 16, 8:07AM CDT
Titan Medical Inc. ("Titan" or the "Company" (TSX: TMD) (OTCQX: TITXF) today announced that it has signed an agreement with a worldwide supplier of endomechanical devices for the development and supply of single patient use robotic tools. Under the terms of the agreement, the supplier will create customized single patient use tools for Titan's SPORTa"c Surgical System.
TMD.TO: 1.41 (unch)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 69

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 573

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 343

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 158

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 587

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 116

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 437

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 131

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 265

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 24

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading

Top 5 Most Recently Viewed Articles

WISeKey Enhances Digital ID Solutions Across Africa

Updated Category News Views 199

WISeKey Expands Its Digital Identity Footprint Across Africa WISeKey International Holding Ltd is making significant strides in transforming digital identity solutions not only within Seychelles but also expanding into several other African nations. As a prominent player in cybersecurity, blockchain, and IoT, WISeKey is set to revolutionize how national ID systems...

Continue Reading
How to Send Event Leads Directly into Your CRM

Updated Category Business Views 149

Trade shows and conferences generate some of the highest-intent leads a sales team will ever encounter. Yet many of those conversations never convert—not because the prospect lost interest, but because the follow-up arrived too late or the contact details were lost somewhere between a badge scanner and a spreadsheet. Research from event marketing surveys consistently...

Continue Reading
Dreame Technology's Innovative Smart Home Solutions at CES 2025

Updated Category News Views 474

Dreame Technology Showcases Innovative Solutions at CES 2025 Dreame Technology, a pioneer in smart home solutions, has made waves at CES 2025 with the introduction of its next-generation smart home ecosystem. This new system streamlines home management and enhances everyday living through intelligent appliances that are easy to use and highly efficient. Revolutionizing...

Continue Reading
Astemo Flexes Aftermarket Muscles at 2026 AAPEX & SEMA

Updated Category News Views 374

Ah, nothing gets car enthusiasts more revved up than a good old-fashioned auto show unveiling. Astemo Americas is strutting its stuff at the 2026 AAPEX and SEMA shows, and they're not just shooting the breeze—this company has got some serious aftermarket muscle to flex. Pumping Up the Aftermarket Game Astemo's not sitting on its hands when it comes to expanding its...

Continue Reading
Cocoa Prices Plummet, Boosting Chocolate Makers Before Holidays

Updated Category News Views 253

Cocoa Prices Reach New Lows Recently, cocoa futures dropped to their lowest point in nearly two years, which is quite timely as we approach the season for hot chocolate and festive gifting. This price decline acts as a unique advantage for chocolate manufacturers who are just starting to see some relief after facing escalating ingredient costs over the past year, coupled...

Continue Reading